Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

High rate of BRAF and RET/PTC dual mutations associated with recurrent papillary thyroid carcinoma.

Clinical cancer research : an official journal of the American Association for Cancer Research - 15 Jan 2009

Henderson Ying C, Shellenberger Thomas D, Williams Michelle D, El-Naggar Adel K, Fredrick Mitchell J, Cieply Kathleen M, Clayman Gary L

Abstract excerpt

PURPOSE: Papillary thyroid carcinoma (PTC), the most common thyroid malignancy, usually possesses BRAF mutation or rearranged in translation (RET)/PTC rearrangements. PTC usually possesses BRAF mutation or RET/PTC rearrangements. The mutation status of patients with recurrent PTC has never been c...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Base Sequence
Share to Carcinoma, Papillary

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to DNA Mutational Analysis

Share to Proto-Oncogene Proteins B-raf

Share to ras Proteins

Share to Recurrence

Share to Thyroid Neoplasms

Source

Open in PubMed Open full text

Identifiers

PMID: 19147753
DOI: 10.1158/1078-0432.CCR-08-0933
PMCID: PMC3038608

Genes

BRAF
RET

Variants

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 2 Sept 2026. Prepared record publication-19147753-2026-09-02.2. Manifest publication-graph-cohort-2026-09-02.2.

Source receipt: PubMed via Helena Literature Corpus, retrieved 2 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

High rate of BRAF and RET/PTC dual mutations associated with recurrent papillary thyroid carcinoma.PMID 19147753Read ↗

Oncogenic alterations in papillary thyroid cancers of young patients.Semantic proximity Read ↗

BRAF mutation in papillary thyroid cancer and its value in tailoring initial treatment: a systematic review and meta-analysis.Semantic proximity Read ↗

Concomitant RAS, RET/PTC, or BRAF mutations in advanced stage of papillary thyroid carcinoma.Semantic proximity Read ↗

BRAFV600E Mutation is Associated with an Increased Risk of Papillary Thyroid Cancer Recurrence.Semantic proximity Read ↗

Genetic Alterations and Their Clinical Implications in High-Recurrence Risk Papillary Thyroid Cancer.Semantic proximity Read ↗

BRAF mutation in papillary thyroid carcinoma: predictive value for long-term prognosis and radioiodine sensitivity.Semantic proximity Read ↗

[BRAF(T1799A) mutation in the primary tumor as a marker of risk, recurrence, or persistence of papillary thyroid carcinoma].Semantic proximity Read ↗

BRAF mutation associated with other genetic events identifies a subset of aggressive papillary thyroid carcinoma.Semantic proximity Read ↗

BRAF(V599E) mutation is the leading genetic event in adult sporadic papillary thyroid carcinomas.Semantic proximity Read ↗

FDG PET/CT imaging in recurrent papillary thyroid cancer: does BRAF mutation status matter?Semantic proximity Read ↗

Association Between <i>BRAF</i> V600E Mutation and Recurrence of Papillary Thyroid CancerSemantic proximity Read ↗

Reoperative central compartment dissection for patients with recurrent/persistent papillary thyroid cancer: efficacy, safety, and the association of the BRAF mutation.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.